IGEA Pharma N.V. / Key word: Preliminary Results/Interim Report
IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters
15-May-2023 / 22:50 CET/CEST
Release of an ad hoc. | May 15, 2023
IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters 15-May-2023 / 22:50 CET/CEST Release of an ad hoc
15.05.2023 - IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report IGEA Pharma N.V.: IGEA to update on unaudited key figures and ongoing matters 15-May-2023 / 22:50 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is . Seite 1
IGEA Pharma N.V. / Key word(s): Preliminary Results/Interim Report15-May-2023 / 22:50 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.IGEA to update on unaudited key figures and ongoing matters Hoofddorp, the Netherlands, 15 M.